These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

139 related items for PubMed ID: 8582050

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Monitoring of bone resorption after renal transplantation by measuring the urinary excretion of pyridinium cross-links.
    Withold W, Degenhardt S, Heins M, Grabensee B, Reinauer H.
    Eur J Clin Chem Clin Biochem; 1995 Jan; 33(1):15-21. PubMed ID: 7756437
    [Abstract] [Full Text] [Related]

  • 3. Simultaneous assessment of bone collagen synthesis and degradation in patients with different malignant tumours. Comparison with the results of 99mTc-methylene bisphosphonate bone scintigraphy.
    Withold W, Georgescu G, Khakzad H, Vosberg H, Mueller-Gaertner HW, Reinauer H.
    Eur J Clin Chem Clin Biochem; 1995 Aug; 33(8):479-85. PubMed ID: 8547430
    [Abstract] [Full Text] [Related]

  • 4. The diagnostic value of urinary pyridinium cross-links of collagen, serum total alkaline phosphatase, and urinary calcium excretion in neoplastic bone disease.
    Pecherstorfer M, Zimmer-Roth I, Schilling T, Woitge HW, Schmidt H, Baumgartner G, Thiébaud D, Ludwig H, Seibel MJ.
    J Clin Endocrinol Metab; 1995 Jan; 80(1):97-103. PubMed ID: 7829646
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Diagnostic validity of bone metabolic markers for bone metastasis.
    Miura H, Yamamoto I, Takada M, Kigami Y, Ohta T, Yuu I, Hamanaka Y, Matsushita R, Morita R.
    Endocr J; 1997 Oct; 44(5):751-7. PubMed ID: 9466334
    [Abstract] [Full Text] [Related]

  • 7. Comparison of bone scintigraphy with bone markers in the diagnosis of bone metastasis in lung carcinoma patients.
    Ebert W, Muley T, Herb KP, Schmidt-Gayk H.
    Anticancer Res; 2004 Oct; 24(5B):3193-201. PubMed ID: 15510610
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Monitoring of multiple myeloma patients by simultaneously measuring marker substances of bone resorption and formation.
    Withold W, Arning M, Schwarz M, Wolf HH, Schneider W.
    Clin Chim Acta; 1998 Jan 12; 269(1):21-30. PubMed ID: 9498101
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Monitoring of bone turnover biological, preanalytical and technical criteria in the assessment of biochemical markers.
    Withold W.
    Eur J Clin Chem Clin Biochem; 1996 Oct 12; 34(10):785-99. PubMed ID: 8933101
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Comparison of biochemical markers of bone resorption in patients with metabolic and malignant bone diseases.
    Withold W, Friedrich W, Reinauer H.
    Ann Clin Biochem; 1996 Sep 12; 33 ( Pt 5)():421-7. PubMed ID: 8888974
    [Abstract] [Full Text] [Related]

  • 14. Analytical and clinical performance characteristics of Tandem-MP Ostase, a new immunoassay for serum bone alkaline phosphatase.
    Broyles DL, Nielsen RG, Bussett EM, Lu WD, Mizrahi IA, Nunnelly PA, Ngo TA, Noell J, Christenson RH, Kress BC.
    Clin Chem; 1998 Oct 12; 44(10):2139-47. PubMed ID: 9761247
    [Abstract] [Full Text] [Related]

  • 15. Pyridinium crosslinks as markers of bone resorption in patients with breast cancer.
    Paterson CR, Robins SP, Horobin JM, Preece PE, Cuschieri A.
    Br J Cancer; 1991 Nov 12; 64(5):884-6. PubMed ID: 1931610
    [Abstract] [Full Text] [Related]

  • 16. Urinary excretion of pyridinium crosslinks: a new marker of bone resorption in metabolic bone disease.
    Uebelhart D, Gineyts E, Chapuy MC, Delmas PD.
    Bone Miner; 1990 Jan 12; 8(1):87-96. PubMed ID: 2106358
    [Abstract] [Full Text] [Related]

  • 17. Discriminative value of biochemical markers of bone turnover in assessing the activity of Paget's disease.
    Alvarez L, Guañabens N, Peris P, Monegal A, Bedini JL, Deulofeu R, Martinez de Osaba MJ, Muñoz-Gomez J, Rivera-Fillat F, Ballesta AM.
    J Bone Miner Res; 1995 Mar 12; 10(3):458-65. PubMed ID: 7785468
    [Abstract] [Full Text] [Related]

  • 18. Urinary excretion of pyridinium cross-links in healthy women; the long-term effects of menopause and oestrogen/progesterone therapy.
    Schlemmer A, Hassager C, Delmas PD, Christiansen C.
    Clin Endocrinol (Oxf); 1994 Jun 12; 40(6):777-82. PubMed ID: 8033369
    [Abstract] [Full Text] [Related]

  • 19. Bone alkaline phosphatase isoenzyme and urinary hydroxyproline in healthy subjects, patients with osteolytic metastases, and patients with primary hyperparathyroidism.
    Stĕpán JJ, Mikulecký M, Bek V, Broulík P, Pacovský V.
    Neoplasma; 1989 Jun 12; 36(4):495-501. PubMed ID: 2770935
    [Abstract] [Full Text] [Related]

  • 20. Serum levels of pyridinium crosslinks in postmenopausal women and in Paget's disease of bone.
    Sinigaglia L, Varenna M, Binelli L, Beltrametti P, Zucchi F, Arrigoni M, Frignani S, Abbiati G.
    Calcif Tissue Int; 1997 Oct 12; 61(4):279-84. PubMed ID: 9312197
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.